Schedule 13G ownership disclosure

TENAX THERAPEUTICS INC

Security class unavailable · CUSIP: 88032L209

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
448,342
Percent of class
6.6500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-20-000275
Form type
SC 13G/A
Filer
RENAISSANCE TECHNOLOGIES LLC
CIK
CIK 1037389
Filed
Feb 13, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub